132 related articles for article (PubMed ID: 25339353)
1. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.
Bockhorn J; Prat A; Chang YF; Liu X; Huang S; Shang M; Nwachukwu C; Gomez-Vega MJ; Harrell JC; Olopade OI; Perou CM; Liu H
Cancer Res; 2014 Dec; 74(24):7406-17. PubMed ID: 25339353
[TBL] [Abstract][Full Text] [Related]
2. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
[TBL] [Abstract][Full Text] [Related]
3. Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation.
Roukens MG; Frederiks CL; Seinstra D; Braccioli L; Khalil AA; Pals C; De Neck S; Bornes L; Beerling E; Mokry M; de Bruin A; Westendorp B; van Rheenen J; Coffer PJ
Oncogene; 2021 Nov; 40(45):6343-6353. PubMed ID: 34584219
[TBL] [Abstract][Full Text] [Related]
4. Lung metastasis genes couple breast tumor size and metastatic spread.
Minn AJ; Gupta GP; Padua D; Bos P; Nguyen DX; Nuyten D; Kreike B; Zhang Y; Wang Y; Ishwaran H; Foekens JA; van de Vijver M; Massagué J
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6740-5. PubMed ID: 17420468
[TBL] [Abstract][Full Text] [Related]
5. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α.
Ren Z; Dharmaratne M; Liang H; Benard O; Morales-Gallego M; Suyama K; Kumar V; Fard AT; Kulkarni AS; Prystowsky M; Mar JC; Norton L; Hazan RB
Br J Cancer; 2024 Apr; 130(6):908-924. PubMed ID: 38238426
[TBL] [Abstract][Full Text] [Related]
6. SND1, a novel co-activator of HIF1α, promotes tumor initiation in PyMT-induced breast tumor.
Hu L; Zeng Y; Xin L; Yang J
FEBS J; 2023 Dec; 290(24):5759-5772. PubMed ID: 37622244
[TBL] [Abstract][Full Text] [Related]
7. miR-203 drives breast cancer cell differentiation.
Martínez-Illescas NG; Leal S; González P; Graña-Castro O; Muñoz-Oliveira JJ; Cortés-Peña A; Gómez-Gil M; Vega Z; Neva V; Romero A; Quintela-Fandino M; Ciruelos E; Sanz C; Aragón S; Sotolongo L; Jiménez S; Caleiras E; Mulero F; Sánchez C; Malumbres M; Salazar-Roa M
Breast Cancer Res; 2023 Aug; 25(1):91. PubMed ID: 37542268
[TBL] [Abstract][Full Text] [Related]
8. A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
Baugh AG; Gonzalez E; Narumi VH; Kreger J; Liu Y; Rafie C; Castanon S; Jang J; Kagohara LT; Anastasiadou DP; Leatherman J; Armstrong T; Chan I; Karagiannis GS; Jaffee EM; MacLean A; Torres ETR
Clin Exp Metastasis; 2024 May; ():. PubMed ID: 38717519
[TBL] [Abstract][Full Text] [Related]
9. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.
Marjanovic ND; Hofree M; Chan JE; Canner D; Wu K; Trakala M; Hartmann GG; Smith OC; Kim JY; Evans KV; Hudson A; Ashenberg O; Porter CBM; Bejnood A; Subramanian A; Pitter K; Yan Y; Delorey T; Phillips DR; Shah N; Chaudhary O; Tsankov A; Hollmann T; Rekhtman N; Massion PP; Poirier JT; Mazutis L; Li R; Lee JH; Amon A; Rudin CM; Jacks T; Regev A; Tammela T
Cancer Cell; 2020 Aug; 38(2):229-246.e13. PubMed ID: 32707077
[TBL] [Abstract][Full Text] [Related]
10. Experimental and spontaneous metastasis assays can result in divergence in clonal architecture.
Serrano A; Weber T; Berthelet J; El-Saafin F; Gadipally S; Charafe-Jauffret E; Ginestier C; Mariadason JM; Oakes SR; Britt K; Naik SH; Merino D
Commun Biol; 2023 Aug; 6(1):821. PubMed ID: 37550477
[TBL] [Abstract][Full Text] [Related]
11. Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
Zhang Q; Padi SK; Tindall DJ; Guo B
Cell Death Dis; 2014 Oct; 5(10):e1486. PubMed ID: 25341040
[TBL] [Abstract][Full Text] [Related]
12. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.
Adorno-Cruz V; Kibria G; Liu X; Doherty M; Junk DJ; Guan D; Hubert C; Venere M; Mulkearns-Hubert E; Sinyuk M; Alvarado A; Caplan AI; Rich J; Gerson SL; Lathia J; Liu H
Cancer Res; 2015 Mar; 75(6):924-9. PubMed ID: 25604264
[TBL] [Abstract][Full Text] [Related]
14. Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts.
de Plater L; Vincent-Salomon A; Berger F; Nicolas A; Vacher S; Gravier E; Thuleau A; Karboul N; Richardson M; Elbaz C; Marangoni E; Bièche I; Paoletti X; Roman-Roman S; Culp PA; Asselain B; Diéras V; Decaudin D
PLoS One; 2014; 9(11):e104227. PubMed ID: 25375638
[TBL] [Abstract][Full Text] [Related]
15. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
Sinha S; Thomas D; Yu L; Gentles AJ; Jung N; Corces-Zimmerman MR; Chan SM; Reinisch A; Feinberg AP; Dill DL; Majeti R
Blood; 2015 Jan; 125(2):316-26. PubMed ID: 25398938
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.
van den Beucken T; Koch E; Chu K; Rupaimoole R; Prickaerts P; Adriaens M; Voncken JW; Harris AL; Buffa FM; Haider S; Starmans MHW; Yao CQ; Ivan M; Ivan C; Pecot CV; Boutros PC; Sood AK; Koritzinsky M; Wouters BG
Nat Commun; 2014 Oct; 5():5203. PubMed ID: 25351418
[TBL] [Abstract][Full Text] [Related]
17. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis.
Wagenblast E; Soto M; Gutiérrez-Ángel S; Hartl CA; Gable AL; Maceli AR; Erard N; Williams AM; Kim SY; Dickopf S; Harrell JC; Smith AD; Perou CM; Wilkinson JE; Hannon GJ; Knott SR
Nature; 2015 Apr; 520(7547):358-62. PubMed ID: 25855289
[TBL] [Abstract][Full Text] [Related]
18. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer.
Zhang L; Deng L; Chen F; Yao Y; Wu B; Wei L; Mo Q; Song Y
Oncotarget; 2014 Nov; 5(21):10665-77. PubMed ID: 25359765
[TBL] [Abstract][Full Text] [Related]
20. ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.
Wang Y; Bu F; Royer C; Serres S; Larkin JR; Soto MS; Sibson NR; Salter V; Fritzsche F; Turnquist C; Koch S; Zak J; Zhong S; Wu G; Liang A; Olofsen PA; Moch H; Hancock DC; Downward J; Goldin RD; Zhao J; Tong X; Guo Y; Lu X
Nat Cell Biol; 2014 Nov; 16(11):1092-104. PubMed ID: 25344754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
